Kazia Therapeutics (KZIA) Short Interest Ratio & Short Volume → RSVP: Charles Payne’s Cash Flow Workshop (From Unstoppable Prosperity) (Ad) Free KZIA Stock Alerts $0.29 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Kazia Therapeutics Short Interest DataCurrent Short Volume18,400 sharesPrevious Short Volume259,500 sharesChange Vs. Previous Month-92.91%Dollar Volume Sold Short$5,648.80Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares16,340,000 sharesPercentage of Shares Shorted0.11%Today's Trading Volume62,051 sharesAverage Trading Volume683,714 sharesToday's Volume Vs. Average9% Short Selling Kazia Therapeutics ? Sign up to receive the latest short interest report for Kazia Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKZIA Short Interest Over TimeKZIA Days to Cover Over TimeKZIA Percentage of Float Shorted Over Time Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Kazia Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202418,400 shares $5,648.80 -92.9%N/A0 $0.31 3/31/2024259,500 shares $80,393.10 +6.9%N/A0.3 $0.31 3/15/2024242,800 shares $54,362.92 -68.3%N/A0.3 $0.22 2/29/2024765,100 shares $195,177.01 +1,566.9%N/A1.1 $0.26 2/15/202445,900 shares $14,242.77 -74.7%N/A0.1 $0.31 1/31/2024181,700 shares $54,328.30 +54.5%N/A1 $0.30 Get the Latest News and Ratings for KZIA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kazia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024117,600 shares $41,148.24 +103.1%N/A1.1 $0.35 12/31/202357,900 shares $25,447.05 +32.8%N/A0.6 $0.44 12/15/202343,600 shares $17,047.60 -40.3%N/A0.5 $0.39 11/30/202373,000 shares $40,931.10 -35.6%N/A0.9 $0.56 11/15/2023113,400 shares $87,658.20 +1,889.5%N/A1.6 $0.77 10/31/20235,700 shares $2,393.43 -95.0%N/A0.1 $0.42 10/15/2023113,800 shares $77,384.00 +116.8%N/A3.1 $0.68 9/30/202352,500 shares $52,250.63 +10.3%N/A1.3 $1.00 9/15/202347,600 shares $48,076.00 -24.3%N/A0.3 $1.01 8/31/202362,900 shares $57,245.29 +10.5%N/A0.3 $0.91 8/15/202356,900 shares $51,329.49 -33.5%N/A0.3 $0.90 7/31/202385,600 shares $86,456.00 -2.5%N/A0.5 $1.01 7/15/202387,800 shares $76,745.98 -36.8%N/A0.5 $0.87 6/30/2023139,000 shares $158,460.00 -3.6%N/A0.8 $1.14 6/15/2023144,200 shares $181,692.00 -10.7%N/A4.7 $1.26 5/31/2023161,500 shares $192,185.00 +20.3%N/A4.8 $1.19 5/15/2023134,300 shares $178,619.00 -24.4%N/A3 $1.33 4/30/2023177,700 shares $236,341.00 +28.2%N/A3.9 $1.33 4/15/2023138,600 shares $182,952.00 -2.0%N/A2.8 $1.32 3/31/2023141,400 shares $145,656.14 +10.0%N/A2.7 $1.03 3/15/2023128,600 shares $120,768.26 -8.5%N/A2.2 $0.94 2/28/2023140,600 shares $129,352.00 -3.8%N/A2.3 $0.92 2/15/2023146,100 shares $131,490.00 -17.3%N/A2.6 $0.90 1/31/2023176,700 shares $182,001.00 -28.5%N/A2.8 $1.03 1/15/2023247,100 shares $259,455.00 +64.2%N/A0.7 $1.05 12/30/2022150,500 shares $92,542.45 -7.8%N/A0.4 $0.61 12/15/2022163,300 shares $89,145.47 -6.1%N/A0.5 $0.55 11/30/2022173,900 shares $104,966.04 -3.4%N/A0.5 $0.60 11/15/2022180,100 shares $118,866.00 -75.8%N/A0.5 $0.66 10/31/2022744,000 shares $614,767.20 +526.3%N/A2.1 $0.83 10/15/2022118,800 shares $118,800.00 +7.1%N/A0.4 $1.00 9/30/2022110,900 shares $121,990.00 -5.9%N/A0.4 $1.10 9/15/2022117,900 shares $168,597.00 -20.7%N/A0.3 $1.43 8/31/2022148,700 shares $227,511.00 -24.8%N/A0.2 $1.53RSVP: Charles Payne’s Cash Flow Workshop (Ad)Are you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.Register For Free Now! KZIA Short Interest - Frequently Asked Questions What is Kazia Therapeutics' current short interest? Short interest is the volume of Kazia Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 18,400 shares of KZIA short. Learn More on Kazia Therapeutics' current short interest. Is Kazia Therapeutics' short interest increasing or decreasing? Kazia Therapeutics saw a drop in short interest in April. As of April 15th, there was short interest totaling 18,400 shares, a drop of 92.9% from the previous total of 259,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kazia Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Kazia Therapeutics: ZyVersa Therapeutics, Inc. (6.14%), Seelos Therapeutics, Inc. (5.48%), NexImmune, Inc. (0.89%), Petros Pharmaceuticals, Inc. (1.69%), Bright Minds Biosciences Inc. (2.76%), Lipella Pharmaceuticals Inc. (1.49%), Synaptogenix, Inc. (3.21%), GT Biopharma, Inc. (0.27%), Genprex, Inc. (2.69%), Tharimmune, Inc. (0.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Kazia Therapeutics stock? Short selling KZIA is an investing strategy that aims to generate trading profit from Kazia Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kazia Therapeutics? A short squeeze for Kazia Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KZIA, which in turn drives the price of the stock up even further. How often is Kazia Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KZIA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ZVSA Short Squeeze SEEL Short Squeeze NEXI Short Squeeze PTPI Short Squeeze DRUG Short Squeeze LIPO Short Squeeze SNPX Short Squeeze GTBP Short Squeeze GNPX Short Squeeze THAR Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KZIA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing